Print

Jan 27, 2021
FSView
PRESS RELEASE

As COVID-19 vaccine distribution continues, the Center for Disease Control (CDC) currently recognizes three dominant variants of the virus found in the United Kingdom, Brazil and South Africa. Zucai Suo, an Eminent Professor and Dorian and John Blackmon chair in Biomedical Science at Florida State University is researching the accuracy of the COVID-19 replications or mutations. 

Press Release

FSU Expert Available to Discuss New COVID-19 Variants

Zucai Suo

FOR IMMEDIATE RELEASE

CONTACT: Bill Wellock, University Communications
(850) 645-1504; wwellock@fsu.edu

@FSUResearch

January 2021

FSU EXPERT AVAILABLE TO DISCUSS NEW COVID-19 VARIANTS 

TALLAHASSEE, Fla. — New variants of the COVID-19 virus have appeared around the world, including a more contagious variant of the COVID-19 virus that was first identified in the United Kingdom. Other variants have been identified in South Africa, Nigeria and Japan.

Viruses constantly change through mutation. Some variants come and go. Others stick around. Florida State University Professor Zucai Suo is available to offer context on why and how viruses mutate and what that change means for COVID-19 and efforts to prevent its spread.

Zucai Suo, Eminent Professor and Dorian and John Blackmon Chair in Biomedical Science, Department of Biomedical Sciences

zucai.suo@med.fsu.edu

Suo’s laboratory is researching how accurately the COVID-19 virus replicates. He also studies the enzymes involved in DNA and RNA replication and repair and has developed FDA-approved antiviral drugs as an industry researcher.

“Virus mutation generally has an error rate that creates diverse populations of genomic mutants, or ‘quasispecies.’ Too many replication mutations are not desirable for any virus’s fitness, but a proper number of mutations allows it to evolve and adapt to new environments and selective pressures. So far, we don’t know the replication error rate of the COVID-19 virus, but it is not surprising that different quasispecies of COVID-19 virus exist in each infected patient. Because of these changes, current antiviral vaccines and therapeutics may lose partial or complete efficacy against some of the quasispecies.”

 

###

 

Photo: Zucai Suo, Eminent Professor and Dorian and John Blackmon Chair in Biomedical Science, Department of Biomedical Sciences at Florida State University. (FSU Photography Services)

Print

Jan 07, 2021
The National Interest
PRESS RELEASE

To date, the United States has witnessed more than 356,000 deaths over the past eleven months of the pandemic—by far the highest total for any country worldwide. Fifteen medical experts including the FSU College of Medicine's Daniel J. Van Durme, chief medical officer of the Florida State University COVID Program and senior associate dean for clinical and community affairs,  spoke to The National Interest about what to expect next.